SOLICITATION NOTICE
A -- PREVENT Preclinical Drug Development Program: Pharmacology & Toxicology Testing - Justification & Approval Document
- Notice Date
- 7/6/2018
- Notice Type
- Justification and Approval (J&A)
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E128, Rockville, Maryland, 20852, United States
- ZIP Code
- 20852
- Solicitation Number
- N0CN45009-91
- Archive Date
- 8/6/2018
- Point of Contact
- Kelly L Dempsey, Phone: 3018466654, Nicole Belanger, Phone: 301 624 8754
- E-Mail Address
-
kelly.dempsey@nih.gov, belangern@mail.nih.gov
(kelly.dempsey@nih.gov, belangern@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Award Number
- Various
- Award Date
- 7/2/2018
- Description
- Signed Justification & Approval Document- PREVENT Pharmacology & Toxicology Testing Please see attached Justification & Approval for PREVENT Preclinical Drug Development: Pharmacology & Toxicology Testing. This notice replaces an earlier notice dated July 3, 2018.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/N0CN45009-91/listing.html)
- Record
- SN04982148-W 20180708/180706230647-5aa26659af20560e8aa63ea116c1342a (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |